/ml) were transfected with Smac n-terminal peptide, H-AVPIAQK-OH, (Calbiochem, Germany) (200 ng), murine recombinant grzB (200 ng) (Sigma) or β -galactosidase (119 kDa subunit) (100-300 ng) as a control using the Chariot protein transfection kit according to the instructions of the manufactures (activemotif, Belgium).
Sample preparation and immunoblotting
Whole cell extracts were prepared by lysing cells in CHAPS lysis buffer (10 mM HEPES, pH 7.4, 150 mM NaCl, 1% CHAPS, protease complete cocktail) on ice for 20 min. Cytosolic extracts were prepared in buffer A (20 mM PIPES, pH 7.0, 50 mM KCl, 2 mM MgCl 2 , 5 mM EGTA, 1 mM dithiothreitol) and mitochondria were isolated as described previously. 21 Mitochondria (300 mg) were treated with recombinant murine Bax protein (200 nM) 22 or Bax storage buffer in 50 µl of MSB supplemented with 5 mM succinate, 5 mM rotenone and 4 mM MgCl 2 at 30 °C for 30 min. Equal amounts of protein were separated by SDS-PAGE. Rabbit polyclonal antiserum specific for human caspase-9, mouse anti-XIAP mAb and mouse anti-cytochrome c mAb were obtained from (BD-laboratories, Heidelberg, Germany). Polyclonal anti-serum specific for caspase-3 was obtained from cell signaling. Polyclonal anti-serum specific for Smac/DIABLO was obtained from Alexis.
Caspase activation
For initiating caspase activation, either 10 µM horse heart cytochrome c (Sigma)
together with 1 mM dATP or 20 ng recombinant murine grzB (Sigma) 23 were added to 20 µl of cell extracts (10 µg/µl) with or without Smac n-terminal peptide, H-AVPIAQK-OH (Calbiochem) (10 µM) for 1h at 30°C. Caspase-3 activity was assayed pENTR construct was generated with a pair of oligonucleotides derived from XIAP mRNA (XIAP-siRNA3) which includes the unique N-19 target as described in pSUPER RNAi system manual (OligoEngine). The vector uses the polymerase-III H1-RNA gene promoter. After generating an entry clone, the pLenti6/V5DEST XIAPsiRNA3 expressing vector was created using LR recombination. The viral particles were produced according to the instructions of the manufactures (pLenti-Dest Gateway system, invitrogen). The recombinant lentiviral constructs were transduced into the cells and stable cell lines were generated using Blasticidin selection.
Anti-CD30 immunoreceptor and engraftment of T cells
The generation of the CD30-specific HRS3-scFv-Fc-zeta immunoreceptor and of the retroviral vector was previously described. 24 To generate GALV-pseudotyped retrovirus, 293T cells were cotransfected with the recombinant vector DNA (6 µg) and with DNA of the retroviral helper plasmids pHIT and pCOLT (each 6 µg DNA/ml), encoding the MMLV gag and pol genes and the GALV envelope gene, respectively.
Peripheral blood lymphocytes were isolated by density centrifugation and cultured for 48h in RPMI 1640 medium, 10% (v/v) FCS in the presence of 400 U/ml IL-2
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From (Endogen) and 100 ng/ml anti-CD3 mAb (OKT3). CD3 + T cells were isolated by magnetic cell sorting procedures using the AutoMACS facility (Miltenyi Biotec). For retroviral transduction, cells were harvested, resuspended in medium with 400 U/ml IL-2, and co-cultured for 48 h with transfected 293T cells. The number of receptor expressing T cells was determined by flow cytometry. T cells were simultaneously incubated with the HRS3 anti-idiotypic mAb 9G10 (IgG1) (10 µg/ml) directed against the scFv binding domain of the immunoreceptor and with the anti-CD3 mAb OKT3 (IgG2a) (5 µg/ml). Bound antibodies were subsequently detected by a FITCconjugated F(ab')2 anti-mouse IgG1 antibody and a PE-conjugated F(ab')2 antimouse IgG2a antibody, respectively, (each 1 µg/ml) (both Southern Biotechnology, Palo Alto, CA). Dead cells were stained by propidium iodide (Sigma, Deisenhofen, Germany). Cells were analyzed by flow cytometry.
Cytotoxicity assay
Specific cytotoxicity of receptor grafted T cells against target cells was monitored after 48 h by a XTT-based colorimetric assay according to the method described by Jost and co-workers. 25 
Redirected cytotoxicity assay
Redirected cytotoxicity was determined according to standard procedures. Briefly, PBMC from healthy volunteer donors were activated at a density of 5x10 6 cells/ml by Concanavalin A (ConA; 2µg/ml) in complete RPMI medium for 5 days. Redirected CTL activity was assayed by co-incubating 51 Cr-labelled target cells at graded effector to target ratios with activated PBMC in the presence of ConA (5µg/ml) for 4h before measuring the activity of 51 Cr in the cell free supernatants of these co-cultures in a gamma counter.
Results

Defective grzB-mediated cytotoxicity in HL B-cells
Hodgkin's lymphoma is mostly associated with an ineffective CTL response against the tumor suggesting immune evasion strategies by tumor cells. 26 As shown in Fig.   1A , the L540 HL cell line was almost completely resistant to cytolysis by ConAactivated CTL from two healthy volunteers, while control target cells, L1309 B-cells and Jurkat T-cells, were readily lysed by the same effector cells. In order to unravel the molecular mechanism of grzB resistance, HL cells were exposed to grzB in the presence of replication-deficient adenovirus (Ad). Like the granular pore-forming protein perforin, Ad facilitates the entry of grzB into the cytoplasm of target cells.
27-28
L428 and L540 HL cells displayed only a minor response to grzB/Ad-treatment (14% and 12% cell death, respectively, after 4h treatment), whereas grzB/Ad induced marked cytotoxicity in L1309 B-cells and Jurkat T-cells (38% and 45%, respectively) (Fig. 1B) . These data suggest that inefficient CTL-mediated cytotoxicity is brought about by resistance of HL cells against grzB action.
GrzB fails to induce mitochondrial release of cytochrome c and Smac in HL cells
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From One hallmark of grzB cytotoxicity is a pro-apoptotic amplification-loop involving mitochondrial release of Smac to overcome the inhibitory effect of XIAP.
13-14 We, therefore, investigated the capability of grzB to initiate mitochondrial release of proapoptotic proteins, Smac and cytochrome c. As shown in Fig 
Cytosolic Smac restores grzB-mediated cytotoxicity in HL B-cells
In order to further define the role of mitochondria in resistance against grzB-mediated cytotoxicity, we selectively bypassed the mitochondria by ectopic cytosolic expression of mature Smac. Once released into the cytosol, Smac interacts with XIAP to release XIAP-mediated inhibition of caspase-3. In cytosolic extracts of untreated L428 cells, cytochrome c/dATP or grzB only partially initiated caspase-3 activity (Fig. 3A) . Addition of the Smac N7 peptide restored caspase-3 activity initiated by cytochrome c/dATP treatment. Similarly, grzB-induced caspase-3 activity was significantly increased upon Smac treatment (Fig. 3A) . Correspondingly, (Fig. 3B) . The potency of Smac to support grzB-mediated cell death was further examined by expression of cytosolic mature Smac lacking the mitochondrial targeting sequence, which was accomplished by using the ubiquitin (Ub) fusion system previously described by Hunter and coworkers. 29 The Ub-Smac fusion protein contains an amino terminal human Ub fused to human mature Smac, which when expressed in the cytosol will be immediately cleaved by a Ub-specific protease to generate the correct AVPI amino terminus of Smac critical for interaction with XIAP. In addition, a dsRed fluorescence tag was added to the carboxyl terminus to allow distinction of the transfected cells.
When L428 HL cells were transiently transfected with DNA constructs expressing UbSmac-dsRed or Ub-dsRed as a control, all fusion proteins displayed diffused, cytoplasmic distribution patterns (Fig. 3C) . The apoptotic capability of grzB was 
XIAP down-regulation in HL B-cells restores grzB-mediated caspase activity
Our finding that cytosolic Smac expression suffices to restore HL cell susceptibility to grzB-induced apoptosis suggested that XIAP is a key inhibitor of grzB-mediated apoptosis in HL cells. If so, down-regulation of XIAP expression should also sensitize HL cell to grzB-induced apoptosis. In order to address this issue we specifically down-regulated XIAP expression by using small hairpin RNA (shRNA) targeting XIAP mRNA. Three shRNA sequences were designed to down-regulate XIAP expression.
All shRNA were first examined in HeLa and HEK293 cells. The most potent shRNA down-regulating XIAP was identified (data not shown) and stably expressed in L540
as well as in L428 cells using lentiviral gene transfer. As shown in Fig. 4A , only HL cells expressing shRNA against XIAP (L428-XIAP-shRNA and L540-XIAP-shRNA) displayed down-regulated XIAP expression, while scrambled (scr) shRNA (L428-scrshRNA and L540-scr-shRNA) remained ineffective. The specificity of XIAP knockdown was revealed by unaltered expression of caspase-3, Smac, and actin.
We next examined whether XIAP down-regulation results in increased grzB-mediated caspase-3 activation/activity in cytosolic extracts of HL cells. GrzB treatment of L428-XIAP-shRNA and L540-XIAP-shRNA depleted of XIAP resulted in caspase-3 autocatalytic activity yielding p17 active caspase-3 ( Fig. 4B ). Addition of grzB to cytosolic extracts from L1309 B-and Jurkat T-cells also lead to initial cleavage of pro-caspase-3, producing the characteristic p20 fragment, which was followed by auto-catalytic activity of caspase-3 eventually generating the p17 mature caspase-3. In contrast, grzB only induced the initial cleavage of caspase-3 generating the p20 fragment of caspase-3 in cytosolic extracts from parental L428 and L540 or from their derivatives expressing scrambled shRNA. Importantly, further auto-catalytic processing was blocked. Consistent with these results, grzB-induced caspase-3 activity was significantly increased in L428-XIAP-shRNA and L540-XIAP-shRNA cells compared to L428, L428-scr-shRNA, L540, and L540-scr-shRNA (Fig. 4C ).
The potential relevance of these observations using cellular lysates was revealed by analyzing grzB-mediated cytotoxicity in intact HL cells expressing XIAP shRNA.
Depletion of XIAP in HL cells resulted in an increased caspase-3 activity after grzB/Ad treatment in L428-XIAP-shRNA and L540-XIAP-shRNA cell lines.
Concomitantly, down-regulation of XIAP restored grzB-mediated cytotoxicity in XIAP-shRNA-L428 and XIAP-shRNA-L540 cell lines (43% and 51% respectively), whereas grzB/Ad-treatment in L428, scr-shRNA-L428, L540, and scr-shRNA-L540 produced only minor cytotoxicity (9%, 14%, and 24%, 20% respectively) ( 
Discussion
In Hodgkin´s lymphoma many defects in apoptotic pathways have been described that may establish resistance to chemotherapeutic agents and contribute to cell survival in general. Here we show that dysfunctional mitochondria in conjunction with up-regulated XIAP expression generate a robust anti-apoptotic barrier protecting HL cells against CTL-induced cytotoxicity. The results of our study indicate that grzBinduced caspase-3 activation is blocked in HL cells at three distinct levels including i) lack of mitochondrial release of cytochrome c needed for the activation of caspase-9, ii) lack of release of Smac needed for disruption of XIAP interaction with caspase-3 and iii) up-regulation of XIAP, the combination of which results in abrogation of grzBinduced caspase-3 activation and CTL-mediated cell death.
GrzB-mediated cytotoxicity by CTLs is principally associated with proteolysis of caspase-3 in the effector stage of apoptosis. 30 The activation of caspase-3 by grzB is known to be a two-step process. Initial cleavage by grzB results in the production of a p20 fragment, which is then ultimately auto-catalytically processed to p17, resulting in a fully active caspase-3. 10 However, caspase-3 is physiologically guarded by IAPs establishing a threshold for its activation. In particular, XIAP binds to the p20 subunit of caspase-3, 31-32 thereby inhibiting its further maturation to p17. [33] [34] As previously reported, strong up-regulation of XIAP expression in HL cell lines and in primary H-RS cells diminished grzB-induced processing of caspase-3 and reduced caspase-3
proteolytic. 19 The results of the present study suggest that mitochondrial dysfunction in HL cells ( For
As shown with activated CTLs redirected to HL cells via expression of a chimeric anti-CD30 immunoreceptor, HL cells are for the most part resistant to CTL-mediated killing (Fig. 7) . CTL-mediated lysis of malignant cells is crucial for the control of tumor surveillance. 36 and L540 (gray bars), were treated with adenovirus at an moi of 100 with or without 600 ng/ml of isolated human grzB and incubated for 4 h at 37°C. Cell death was determined after 2 h. C) HL cells L428 were transiently transfected with Ub-Smac-dsRed or Ub-dsRed (red). Cells were left untreated or treated with grzB/Ad. After fixation nuclei were stained (Hoechst 33258) (blue) and analysed by motorised inverted microscope (Olympus Ix81) using a 63x/1.40 Planapo oil objective. Images were acquired with Analysis software (soft imaging system) and were further processed and assembled using power point. L428-XIAP-shRNA were prepared and equal amounts of protein were incubated with grzB (20 ng) for 1h at 30°C. Cytosolic extracts were resolved by SDS/PAGE and subjected to western blot analysis for caspase-3 by polyclonal rabbit anti-caspase-3
antibody. Reprobing for actin ensured equal loading. C) Relative caspase-3 activity was analyzed in the cytosolic extracts after grzB treatment using DEVD-AFC as substrate.
Fig. 5. XIAP down-regulation restores apoptotic capability of grzB in HL cells.
A) 10 6 L1309 B-cells, Jurkat T-cells, or HL cells L428, L428-scr-shRNA, L428-XIAPshRNA, L540, L540-scr-shRNA, L540-XIAP-shRNA were left untreated or treated with adenovirus (moi of 100), isolated human grzB (600 ng), or adenovirus (moi of 100) plus isolated human grzB (600 ng). After 2 h cytosolic extracts were isolated and caspase-3 activity was measured using DEVD-AFC as substrate. Cell death was assessed after 4 h. Viability of target cells was monitored by a XTT-based colorimetric assay. For personal use only. on October 31, 2017. by guest www.bloodjournal.org From
